Risk of Erectile Dysfunction in Male Patients with Gout Treated with Febuxostat or Allopurinol: A Propensity Score-Matched Cohort Study.

Qiang TongYu DuRan CuiMiao ChenShiow-Ing WangJames Cheng-Chung WeiSheng-Ming Dai
Published in: Drugs (2022)
Febuxostat may be associated with a higher risk of ED than allopurinol in adult male patients with gout. Future large-scale prospective studies are warranted to confirm our results.